There are several things to consider. The DNP will antagonize some aspects of the action of the Glucovance.
Glucovance is a combination of two agents, metformin and glyburide. The metformin lowers blood sugar by reducing glucose production in the liver and by increasing glucose uptake by cells. Impeding glucose absorption from the intestine is thought to be a mechanism as well.
Glyburide increases insulin production and increases insulin stimulated glucose transport into cells.
As you may know, the pancreas secretes glucagon in response to low blood sugar levels. Glucagon has the opposite action of insulin: it increases blood sugar by stimulating glucose production by the liver, and it inhibits insulin stimulated glucose transport into cells. So glucagon also has the opposite action of Glucovance
Where is all this going? It turns out that DNP increases glucagon production (1). This is why I originally said that DNP would antagonize the action of Glucovance, and one way it does it by stimulating glucagon production.
Even though DNP itself increases glucose uptake in cells in a normal person, the glucagon stimulated glucose production offsets this leading to hyperglycemia. (This is the reason DNP causes cataracts. In diabetics, cataracts often form as a result of long term uncontrolled hyperglycemia). This problem will only be exacerbated by your friends insulin resistance.
DNP also seems to block glyburide's ability to stimulate insulin secretion from the pancreas (2).
During a short course of DNP the elevated blood sugar would probably not be a problem. Unfortunately there are potentially more serious things to consider.
Lactic acidosis is a potential serious side effect of Metformin. DNP induces lactic acidosis as well. (DNP blocks oxidative phosphorylation in cells, forcing them to use the glycolytic pathway to produce ATP. Lactic acid is the end product.)
The combination of the metformin and DNP could lead to serious acidosis, especially in someone working out. (Lactic acid is what causes the burn from lifting, sprinting, etc.)
Another thing to consider is that the sulfonylurea drugs like glyburide are also mild mitochondrial uncouplers, like DNP. Combining the two could be like taking an extra strong dose of DNP, with potential dangerous side effects.
(1) Biochim Biophys Acta 1980 Mar 3;628(2):152-60
Effects of metabolic inhibitors on the regulation of pancreatic glucagon release.
Ostenson CG, Agren A, Andersson A.
(2) Am J Physiol 1998 Jan;274(1 Pt 1):E38-44
Metabolic inhibition impairs ATP-sensitive K+ channel block by sulfonylurea in pancreatic beta-cells.
Mukai E, Ishida H, Kato S, Tsuura Y, Fujimoto S, Ishida-Takahashi A, Horie M, Tsuda K, Seino Y.
www.Triedia.com